Clinical trial
Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal…
NCT00248066 · Sarepta Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00248066 |
|---|---|
| Title | Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries |
| Official title | APPRAISAL Trial: A Phase IIa Study to Evaluate the Safety and Preliminary Efficacy of RESTEN-MP® When Used in Conjunction With a Bare Metal Stent in de Novo Native Coronary Artery Lesions |
| Lead sponsor | Sarepta Therapeutics, Inc., Industry |
| Collaborators | Baim Institute for Clinical Research |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Coronary Restenosis |
| Intervention type | Drug |
| Interventions | RESTEN-MP |
| Enrollment | 50 |
| Start date | Sep 1, 2005 |
| First posted | Nov 3, 2005 |
| Last update posted | Feb 8, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: